DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
DA, Elizabeth Jungman, J.D., M.P.H. Chief of Staff of the FDA | Official Website
This is a 200% increase over the number of companies inspected in the previous quarter, when two companies received two inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics and Drugs sectors. Both the Biologics and Devices sectors sectors tied for second most common type.
There were three companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. Three should take voluntary action to correct their management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Balassa Laboratories, Inc. | Drugs | 04/07/2023 | Voluntary Action Indicated (VAI) |
Biomat USA, Inc. | Biologics | 06/07/2023 | No Action Indicated (NAI) |
DFA Dairy Brands Fluid, LLC | Food and Cosmetics | 04/18/2023 | No Action Indicated (NAI) |
Jogue, Inc. | Food and Cosmetics | 05/23/2023 | No Action Indicated (NAI) |
NeuroVention, LLC | Devices | 05/31/2023 | Voluntary Action Indicated (VAI) |
Playtex Manufacturing, Inc. | Drugs | 04/19/2023 | Voluntary Action Indicated (VAI) |